Literature DB >> 27040448

Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.

Neil P Roberts1, Pamela A Roberts, Neil Jones, Jonathan I Bisson.   

Abstract

BACKGROUND: Post-traumatic stress disorder (PTSD) is a debilitating mental health disorder that may develop after exposure to traumatic events. Substance use disorder (SUD) is a behavioural disorder in which the use of one or more substances is associated with heightened levels of distress, clinically significant impairment of functioning, or both. PTSD and SUD frequently occur together. The comorbidity is widely recognised as being difficult to treat and is associated with poorer treatment completion and poorer outcomes than for either condition alone. Several psychological therapies have been developed to treat the comorbidity, however there is no consensus about which therapies are most effective.
OBJECTIVES: To determine the efficacy of psychological therapies aimed at treating traumatic stress symptoms, substance misuse symptoms, or both in people with comorbid PTSD and SUD in comparison with control conditions (usual care, waiting-list conditions, and no treatment) and other psychological therapies. SEARCH
METHODS: We searched the Cochrane Depression, Anxiety and Neurosis Group's Specialised Register (CCDANCTR) all years to 11 March 2015. This register contains relevant randomised controlled trials from the Cochrane Library (all years), MEDLINE (1950 to date), EMBASE (1974 to date), and PsycINFO (1967 to date). We also searched the World Health Organization International Clinical Trials Registry Platform and ClinicalTrials.gov, contacted experts, searched bibliographies of included studies, and performed citation searches of identified articles. SELECTION CRITERIA: Randomised controlled trials of individual or group psychological therapies delivered to individuals with PTSD and comorbid substance use, compared with waiting-list conditions, usual care, or minimal intervention or to other psychological therapies. DATA COLLECTION AND ANALYSIS: We used standard methodological procedures expected by Cochrane. MAIN
RESULTS: We included 14 studies with 1506 participants, of which 13 studies were included in the quantitative synthesis. Most studies involved adult populations. Studies were conducted in a variety of settings. We performed four comparisons investigating the effects of psychological therapies with a trauma-focused component and non-trauma-focused interventions against treatment as usual/minimal intervention and other active psychological therapies. Comparisons were stratified for individual- or group-based therapies. All active interventions were based on cognitive behavioural therapy. Our main findings were as follows.Individual-based psychological therapies with a trauma-focused component plus adjunctive SUD intervention was more effective than treatment as usual (TAU)/minimal intervention for PTSD severity post-treatment (standardised mean difference (SMD) -0.41; 95% confidence interval (CI) -0.72 to -0.10; 4 studies; n = 405; very low-quality evidence) and at 3 to 4 and 5 to 7 months' follow-up. There was no evidence of an effect for level of drug/alcohol use post-treatment (SMD -0.13; 95% CI -0.41 to 0.15; 3 studies; n = 388; very low-quality evidence), but there was a small effect in favour of individual psychological therapy at 5 to 7 months (SMD -0.28; 95% CI -0.48 to -0.07; 3 studies; n = 388) when compared against TAU. Fewer participants completed trauma-focused therapy than TAU (risk ratio (RR) 0.78; 95% CI 0.64 to 0.96; 3 studies; n = 316; low-quality evidence).Individual-based psychological therapy with a trauma-focused component did not perform better than psychological therapy for SUD only for PTSD severity (mean difference (MD) -3.91; 95% CI -19.16 to 11.34; 1 study; n = 46; low-quality evidence) or drug/alcohol use (MD -1.27; 95% CI -5.76 to 3.22; 1 study; n = 46; low-quality evidence). Findings were based on one small study. No effects were observed for rates of therapy completion (RR 1.00; 95% CI 0.74 to 1.36; 1 study; n = 62; low-quality evidence).Non-trauma-focused psychological therapies did not perform better than TAU/minimal intervention for PTSD severity when delivered on an individual (SMD -0.22; 95% CI -0.83 to 0.39; 1 study; n = 44; low-quality evidence) or group basis (SMD -0.02; 95% CI -0.19 to 0.16; 4 studies; n = 513; low-quality evidence). There were no data on the effects on drug/alcohol use for individual therapy. There was no evidence of an effect on the level of drug/alcohol use for group-based therapy (SMD -0.03; 95% CI -0.37 to 0.31; 4 studies; n = 414; very low-quality evidence). A post-hoc analysis for full dose of a widely established group therapy called Seeking Safety showed reduced drug/alcohol use post-treatment (SMD -0.67; 95% CI -1.14 to -0.19; 2 studies; n = 111), but not at subsequent follow-ups. Data on the number of participants completing therapy were not for individual-based therapy. No effects were observed for rates of therapy completion for group-based therapy (RR 1.13; 95% CI 0.88 to 1.45; 2 studies; n = 217; low-quality evidence).Non-trauma-focused psychological therapy did not perform better than psychological therapy for SUD only for PTSD severity (SMD -0.26; 95% CI -1.29 to 0.77; 2 studies; n = 128; very low-quality evidence) or drug/alcohol use (SMD 0.22; 95% CI -0.13 to 0.57; 2 studies; n = 128; low-quality evidence). No effects were observed for rates of therapy completion (RR 0.91; 95% CI 0.68 to 1.20; 2 studies; n = 128; very low-quality evidence).Several studies reported on adverse events. There were no differences between rates of such events in any comparison. We rated several studies as being at 'high' or 'unclear' risk of bias in multiple domains, including for detection bias and attrition bias. AUTHORS'
CONCLUSIONS: We assessed the evidence in this review as mostly low to very low quality. Evidence showed that individual trauma-focused psychological therapy delivered alongside SUD therapy did better than TAU/minimal intervention in reducing PTSD severity post-treatment and at long-term follow-up, but only reduced SUD at long-term follow-up. All effects were small, and follow-up periods were generally quite short. There was evidence that fewer participants receiving trauma-focused therapy completed treatment. There was very little evidence to support use of non-trauma-focused individual- or group-based integrated therapies. Individuals with more severe and complex presentations (e.g. serious mental illness, individuals with cognitive impairment, and suicidal individuals) were excluded from most studies in this review, and so the findings from this review are not generalisable to such individuals. Some studies suffered from significant methodological problems and some were underpowered, limiting the conclusions that can be drawn. Further research is needed in this area.

Entities:  

Mesh:

Year:  2016        PMID: 27040448      PMCID: PMC8782594          DOI: 10.1002/14651858.CD010204.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  126 in total

Review 1.  A multidimensional meta-analysis of psychotherapy for PTSD.

Authors:  Rebekah Bradley; Jamelle Greene; Eric Russ; Lissa Dutra; Drew Westen
Journal:  Am J Psychiatry       Date:  2005-02       Impact factor: 18.112

2.  The impact of post-traumatic stress disorder on treatment outcomes for heroin dependence.

Authors:  Katherine L Mills; Maree Teesson; Joanne Ross; Shane Darke
Journal:  Addiction       Date:  2007-03       Impact factor: 6.526

3.  Childhood trauma among individuals with co-morbid substance use and post traumatic stress disorder.

Authors:  Philippa L Farrugia; Katherine L Mills; Emma Barrett; Sudie E Back; Maree Teesson; Amanda Baker; Claudia Sannibale; Sally Hopwood; Julia Rosenfeld; Sabine Merz; Kathleen T Brady
Journal:  Ment Health Subst Use       Date:  2011-11

Review 4.  Review of treatment recommendations for persons with a co-occurring affective or anxiety and substance use disorder.

Authors:  Katherine E Watkins; Sarah B Hunter; M Audrey Burnam; Harold Alan Pincus; Gina Nicholson
Journal:  Psychiatr Serv       Date:  2005-08       Impact factor: 3.084

5.  Concurrent treatment of posttraumatic stress disorder and alcohol dependence: Predictors and moderators of outcome.

Authors:  Laurie J Zandberg; David Rosenfield; Carmen P McLean; Mark B Powers; Anu Asnaani; Edna B Foa
Journal:  J Consult Clin Psychol       Date:  2015-10-12

Review 6.  Treatment of co-occurring posttraumatic stress disorder and substance use disorders.

Authors:  Erin C Berenz; Scott F Coffey
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

7.  Family composition and symptom severity among Veterans with comorbid PTSD and substance use disorders.

Authors:  Lisa Jobe-Shields; Julianne C Flanagan; Therese Killeen; Sudie E Back
Journal:  Addict Behav       Date:  2015-06-11       Impact factor: 3.913

8.  Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Robert H Pietrzak; Risë B Goldstein; Steven M Southwick; Bridget F Grant
Journal:  J Anxiety Disord       Date:  2010-11-26

9.  The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders.

Authors:  Elizabeth C Saunders; Mark P McGovern; Chantal Lambert-Harris; Andrea Meier; Bethany McLeman; Haiyi Xie
Journal:  Am J Addict       Date:  2015-09-21

10.  Posttraumatic stress disorder in the National Comorbidity Survey.

Authors:  R C Kessler; A Sonnega; E Bromet; M Hughes; C B Nelson
Journal:  Arch Gen Psychiatry       Date:  1995-12
View more
  33 in total

1.  Methods to reduce false reporting of substance abstinence in clinical research.

Authors:  Sandra J Japuntich; Kimberly A Arditte Hall; Celina M Joos; Ann M Rasmusson; Suzanne L Pineles
Journal:  Int J Methods Psychiatr Res       Date:  2018-01-04       Impact factor: 4.035

Review 2.  Unravelling the Link Between Prenatal Stress, Dopamine and Substance Use Disorder.

Authors:  Verónica Pastor; Marta Cristina Antonelli; María Eugenia Pallarés
Journal:  Neurotox Res       Date:  2016-10-24       Impact factor: 3.911

3.  Been There, Done That: Lessons from Vancouver's Efforts to Stem the Tide of Overdose Deaths.

Authors:  Michael R Krausz; James S H Wong; Ehsan Moazen-Zadeh; Kerry L Jang
Journal:  Can J Psychiatry       Date:  2020-03-16       Impact factor: 4.356

4.  Alcohol-related and mental health care for patients with unhealthy alcohol use and posttraumatic stress disorder in a National Veterans Affairs cohort.

Authors:  Jessica A Chen; Mandy D Owens; Kendall C Browne; Emily C Williams
Journal:  J Subst Abuse Treat       Date:  2017-11-22

5.  Development of a novel, integrated cognitive-behavioral therapy for co-occurring posttraumatic stress and substance use disorders: A pilot randomized clinical trial.

Authors:  Anka A Vujanovic; Lia J Smith; Charles E Green; Scott D Lane; Joy M Schmitz
Journal:  Contemp Clin Trials       Date:  2017-12-26       Impact factor: 2.226

Review 6.  Managing Pain and Psychosocial Care in IBD: a Primer for the Practicing Gastroenterologist.

Authors:  Emily Weaver; Eva Szigethy
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

7.  Internet-based cognitive and behavioural therapies for post-traumatic stress disorder (PTSD) in adults.

Authors:  Natalie Simon; Lindsay Robertson; Catrin Lewis; Neil P Roberts; Andrew Bethell; Sarah Dawson; Jonathan I Bisson
Journal:  Cochrane Database Syst Rev       Date:  2021-05-20

Review 8.  Pharmacotherapy for anxiety and comorbid alcohol use disorders.

Authors:  Jonathan C Ipser; Don Wilson; Taiwo O Akindipe; Carli Sager; Dan J Stein
Journal:  Cochrane Database Syst Rev       Date:  2015-01-20

9.  A randomized comparison trial of culturally adapted HIV prevention approaches for Native Americans reducing trauma symptoms versus substance misuse: The Healing Seasons protocol.

Authors:  C R Pearson; D Kaysen; D Huh; M Bedard-Gillgan; D Walker; R Marin; K Saluskin
Journal:  Contemp Clin Trials       Date:  2020-06-17       Impact factor: 2.226

10.  Psychosocial Interventions for Amphetamine Type Stimulant Use Disorder: An Overview of Systematic Reviews.

Authors:  Mai Thi Ngoc Tran; Quang Hung Luong; Giang Le Minh; Michael P Dunne; Philip Baker
Journal:  Front Psychiatry       Date:  2021-06-17       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.